Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121241812 | 12124181 | 2 | F | 20160209 | 20160908 | 20160228 | 20160920 | EXP | GB-MHRA-EYC 00135175 | GB-TEVA-636395ACC | TEVA | 83.00 | YR | F | Y | 50.80000 | KG | 20160920 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121241812 | 12124181 | 1 | PS | TRIMETHOPRIM. | TRIMETHOPRIM | 1 | Oral | 400 MILLIGRAM DAILY; | 1200 | MG | N | U | 18679 | 200 | MG | BID | |||
| 121241812 | 12124181 | 2 | C | ALENDRONATE | ALENDRONATE SODIUM | 1 | 0 | 70 | MG | /wk | |||||||||
| 121241812 | 12124181 | 3 | C | BECLOMETASONE | BECLOMETHASONE DIPROPIONATE | 1 | Respiratory (inhalation) | 400 MICROGRAM DAILY; | 0 | 200 | UG | BID | |||||||
| 121241812 | 12124181 | 4 | C | LERCANIDIPINE | LERCANIDIPINE | 1 | 10 MILLIGRAM DAILY; | 0 | 10 | MG | QD | ||||||||
| 121241812 | 12124181 | 5 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 75 MICROGRAM DAILY; | 0 | 75 | UG | QD | ||||||||
| 121241812 | 12124181 | 6 | C | RAMIPRIL. | RAMIPRIL | 1 | 10 MILLIGRAM DAILY; | 0 | 10 | MG | QD | ||||||||
| 121241812 | 12124181 | 7 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 40 MILLIGRAM DAILY; | 0 | 40 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121241812 | 12124181 | 1 | Urinary tract infection |
| 121241812 | 12124181 | 2 | Osteoporosis |
| 121241812 | 12124181 | 3 | Asthma |
| 121241812 | 12124181 | 4 | Essential hypertension |
| 121241812 | 12124181 | 5 | Hypothyroidism |
| 121241812 | 12124181 | 6 | Essential hypertension |
| 121241812 | 12124181 | 7 | Hypercholesterolaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121241812 | 12124181 | OT |
| 121241812 | 12124181 | HO |
| 121241812 | 12124181 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121241812 | 12124181 | Dizziness | |
| 121241812 | 12124181 | Hyponatraemia | |
| 121241812 | 12124181 | Muscular weakness | |
| 121241812 | 12124181 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121241812 | 12124181 | 1 | 20160206 | 20160209 | 0 |